This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

Back

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

MDS - 775

Real-World Outcomes With Early Adoption of Imetelstat in Patients With Transfusion-Dependent Myelodysplastic Syndromes (MDS): Insights From a United States (US) Community Oncology Chart Review

Preview of Real-World Outcomes With Early Adoption of Imetelstat in Patients With Transfusion-Dependent Myelodysplastic Syndromes (MDS): Insights From a United States (US) Community Oncology Chart Review

View Poster Contact Presenter

Poster Presenter

Jessy Thomas

Authors

Jessy Thomas

Part of Topic

Myelodysplastic Syndromes (MDS)

Early Real-World Use and Hematologic Outcomes With Imetelstat in Patients With Myelodysplastic Syndromes: Insights From a United States Community Oncology Chart Review

Other ePosters in

Topic

MDS - 098Artificial Intelligence in the Diagnosis of Severe Aplastic Anemia: A Sy...

MDS - 1007Rising Mortality and Persistent Disparities in Hematologic Malignancies...

MDS - 1034Cooperative Effects of U2AF1-S34 and BCOR Mutations in Myeloid Neoplasms

MDS - 1049Spliceosome-Targeting Therapies in SF3B1-Mutated Myelodysplastic Syndrom...

MDS - 1074A Phase 2 Open-Label Study to Assess the Tolerability of Ianalumab (VAY7...

ePosters in

Topics

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)